Clinical trial
S9630, Medroxyprogesterone in Treating Women With Breast Cancer
NCT00002920 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00002920 |
|---|---|
| Title | S9630, Medroxyprogesterone in Treating Women With Breast Cancer |
| Official title | A Randomized Comparison Of Medroxyprogesterone Acetate (MA) And Observation For Prevention Of Endometrial Pathology In Postmenopausal Breast Cancer Patients Treated With Tamoxifen, Phase III |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH Cancer and Leukemia Group B |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Endometrial Cancer |
| Intervention type | Drug, Procedure |
| Interventions | medroxyprogesterone, tamoxifen citrate, adjuvant therapy |
| Enrollment | 313 |
| Start date | Mar 1, 1997 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 31, 2012 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: